🇺🇸 FDA
Patent

US 9402898

Stabilized formulations containing anti-Ang2 antibodies

granted A61KA61K39/3955A61K39/39591

Quick answer

US patent 9402898 (Stabilized formulations containing anti-Ang2 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K39/3955, A61K39/39591, A61K47/183, A61K47/26